Приказ основних података о документу

dc.creatorMiljević, Čedo D.
dc.creatorNikolić-Kokić, Aleksandra
dc.creatorBlagojević, Duško
dc.creatorMilovanović, Maja
dc.creatorMunjiza, Ana
dc.creatorJukić, Marin M
dc.creatorPešić, Vesna
dc.creatorLečić-Toševski, Dušica
dc.creatorSpasić, Mihajlo
dc.date.accessioned2018-10-08T12:36:27Z
dc.date.available2900-01-01
dc.date.issued2018
dc.identifier.issn0165-1781
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0165178117323272?via%3Dihub
dc.identifier.urihttps://radar.ibiss.bg.ac.rs/handle/123456789/3154
dc.description.abstractTo determine the relationship between alterations in the activity of the enzymes participating in antioxidative defense system and neurological soft signs (NSS) in schizophrenic patients with the first episode psychosis (SFE, n = 19), patients in relapse (SR, n = 46), and healthy controls (HC, n = 20). NSS intensity and enzymatic plasma activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX) were compared between SFE, SR and HC subjects and a follow-up correlation analyses between the enzyme activities and NSS intensity was performed. NSS intensity was increased four times in schizophrenic patients compared with healthy controls. Activities of SOD and CAT were 40% decreased in SFE and these reductions were ameliorated by antipsychotic treatment. GPX activity was 20% decreased in both patient groups compared with controls. A negative correlation between NSS intensity and GPX activity was specifically found in the SFE patients. The data in this report argue that a reduction of GPX activity might be one of the causes for the emergence of NSS at the onset of schizophrenia, and provide the evidence that antipsychotic therapy can attenuate activity reductions of SOD and CAT, but not the activity reduction of GPX and the intensity of NSS.en
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173014/RS//
dc.rightsrestrictedAccess
dc.sourcePsychiatry research
dc.titleAssociation between neurological soft signs and antioxidant enzyme activity in schizophrenic patients.en
dc.typearticleen
dc.rights.licenseARR
dcterms.abstractЈукић, Марин М; Спасић, Михајло; Пешић, Весна; Лечић-Тошевски, Душица; Николић-Кокић, Aлександра; Благојевић, Душко; Миљевић, Чедо Д.; Миловановић, Маја; Муњиза, Aна;
dc.rights.holder© 2018 Elsevier B.V.
dc.citation.volume269
dc.identifier.doi10.1016/j.psychres.2018.09.009
dc.identifier.pmid30273900
dc.identifier.scopus2-s2.0-85053528799
dc.identifier.wos000449902700107
dc.citation.apaMiljević, Č. D., Nikolić-Kokić, A., Blagojević, D., Milovanović, M., Munjiza, A., Jukić, M. M., … Spasić, M. B. (2018). Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients. Psychiatry Research, 269, 746–752.
dc.citation.vancouverMiljević ČD, Nikolić-Kokić A, Blagojević D, Milovanović M, Munjiza A, Jukić MM, Pešić V, Lečić-Toševski D, Spasić MB. Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients. Psychiatry Res. 2018;269:746–52.
dc.citation.spage746
dc.citation.epage752
dc.type.versionpublishedVersionen
dc.citation.rankM22


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу